Zuranolone in Postpartum Depression: Mechanistic Innovation, Clinical Evidence, and Translational Uncertainty.

Zavaleta-Monestel E, Herrera-Jiménez LG, González-Aguilar K, Mora-Jiménez J, Millán González R

Open source

DOI
10.7759/cureus.114673
Published
2026 Aug
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.114673,
  title = {Zuranolone in Postpartum Depression: Mechanistic Innovation, Clinical Evidence, and Translational Uncertainty.},
  author = {Zavaleta-Monestel E and Herrera-Jiménez LG and González-Aguilar K and Mora-Jiménez J and Millán González R},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.114673},
  url = {https://doi.org/10.7759/cureus.114673}
}

RIS

TY  - JOUR
TI  - Zuranolone in Postpartum Depression: Mechanistic Innovation, Clinical Evidence, and Translational Uncertainty.
AU  - Zavaleta-Monestel E
AU  - Herrera-Jiménez LG
AU  - González-Aguilar K
AU  - Mora-Jiménez J
AU  - Millán González R
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.114673
UR  - https://doi.org/10.7759/cureus.114673
ER  - 

APA

E, Z., LG, H., K, G., J, M., & R, M. G. (2026). Zuranolone in Postpartum Depression: Mechanistic Innovation, Clinical Evidence, and Translational Uncertainty.. Cureus. https://doi.org/10.7759/cureus.114673

Source records